Evidence-Based Guidance for One Health Preparedness, Prevention, and Response Strategies to Marburg Virus Disease Outbreaks
- PMID: 39727639
- PMCID: PMC11727285
- DOI: 10.3390/diseases12120309
Evidence-Based Guidance for One Health Preparedness, Prevention, and Response Strategies to Marburg Virus Disease Outbreaks
Abstract
Objectives: Marburg virus disease (MVD) is on the WHO list for pandemic-prone pathogens. The current outbreak in Rwanda provides an opportunity to map outbreaks and generate information to inform policymaking, resource mobilization, and guide the implementation of cost-effective response strategies.
Methods: We synthesized available information about MVD to build holistic, up-to-date evidence to inform policymakers, public health leaders, and healthcare and public health services providers in their development and implementation of cost-effective preparedness, prevention, and control measures.
Results: We have identified 20 outbreaks of MVD that occurred in 14 countries between 1967 and 2024; these outbreaks led to 580 confirmed cases and 423 deaths in total. We summarize the available information about the main clinical signs, diagnostic tools, primary reservoir, transmission dynamics, and case management protocol. We also document the best practices in the prevention and control of MVD outbreaks, including the implementation of a multisectoral One Health strategy for preparedness, prevention, and response to MVD outbreaks that incorporates the strict implementation of WASH and infection prevention measures, contact tracing, and the isolation of infected and suspected humans and animals, and enhances the implementation of the International Health Regulations, particularly efficient cross-country coordination.
Conclusions: In the absence of a licensed treatment or vaccine for MVD, the response strategy to MVD should focus on preventive measures, including community engagement to promote the reduction in contact between humans and reservoirs, the supportive care and isolation of patients, and proper waste management. High risk populations such as frontline responders, including healthcare providers and community health workers, should be prioritized so that they can access all currently available protection measures.
Keywords: Africa; global health security; hemorrhagic fever; multisectoral one health strategy; pandemic preparedness; pandemic-prone diseases; prevention; response; zoonotic-viral infection.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Marburg virus disease in Rwanda: an observational study of the first 10 days of outbreak response, clinical interventions, and outcomes.BMC Med. 2025 May 20;23(1):292. doi: 10.1186/s12916-025-04123-w. BMC Med. 2025. PMID: 40394565 Free PMC article.
-
The neglected continuously emerging Marburg virus disease in Africa: A global public health threat.Health Sci Rep. 2023 Oct 29;6(11):e1661. doi: 10.1002/hsr2.1661. eCollection 2023 Nov. Health Sci Rep. 2023. PMID: 37908639 Free PMC article.
-
Infection prevention and control of highly infectious pathogens in resource-limited countries: an experience from Marburg viral disease outbreak in Kagera Region - Tanzania.BMC Infect Dis. 2024 Jun 24;24(1):628. doi: 10.1186/s12879-024-09508-5. BMC Infect Dis. 2024. PMID: 38914946 Free PMC article.
-
Mapping the zoonotic niche of Marburg virus disease in Africa.Trans R Soc Trop Med Hyg. 2015 Jun;109(6):366-78. doi: 10.1093/trstmh/trv024. Epub 2015 Mar 27. Trans R Soc Trop Med Hyg. 2015. PMID: 25820266 Free PMC article. Review.
-
Marburg Virus Disease: Pathophysiology, Diagnostic Challenges, and Global Health Preparedness Strategies.Ann Glob Health. 2025 Jun 2;91(1):24. doi: 10.5334/aogh.4671. eCollection 2025. Ann Glob Health. 2025. PMID: 40487708 Free PMC article. Review.
Cited by
-
Genomic Evolution and Phylodynamics of the Species Orthomarburgvirus marburgense (Marburg and Ravn Viruses) to Understand Viral Adaptation and Marburg Virus Disease's Transmission Dynamics.Pathogens. 2024 Dec 14;13(12):1107. doi: 10.3390/pathogens13121107. Pathogens. 2024. PMID: 39770366 Free PMC article. Review.
-
Rift Valley Fever in Rwanda Is Urging for Enhancing Global Health Security Through Multisectoral One Health Strategy.Microorganisms. 2025 Jan 5;13(1):91. doi: 10.3390/microorganisms13010091. Microorganisms. 2025. PMID: 39858859 Free PMC article. Review.
-
Therapeutic advances in Marburg virus disease: from experimental treatments to vaccine development.Ann Med Surg (Lond). 2025 Mar 28;87(5):2784-2799. doi: 10.1097/MS9.0000000000003213. eCollection 2025 May. Ann Med Surg (Lond). 2025. PMID: 40337393 Free PMC article. Review.
-
Kinetics of hematological and biochemical biomarkers are key tools for monitoring disease progression in Marburg virus-infected patients in Rwanda.Sci Rep. 2025 Jul 1;15(1):21405. doi: 10.1038/s41598-025-04732-8. Sci Rep. 2025. PMID: 40593942 Free PMC article.
-
Immunogenicity, Pathogenesis, and Host's Immuno-Responses to Marburg Virus Infection.Pathogens. 2025 Mar 27;14(4):323. doi: 10.3390/pathogens14040323. Pathogens. 2025. PMID: 40333058 Free PMC article. Review.
References
-
- The World Health Organization (WHO) Marburg Virus Disease. [(accessed on 9 October 2024)]. Available online: https://www.who.int/health-topics/marburg-virus-disease.
-
- Srivastava S., Sharma D., Kumar S., Sharma A., Rijal R., Asija A., Adhikari S., Rustagi S., Sah S., Al-Qaim Z.H., et al. Emergence of Marburg virus: A global perspective on fatal outbreaks and clinical challenges. Front. Microbiol. 2023;14:1239079. doi: 10.3389/fmicb.2023.1239079. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources